Company Profiles

driven by the PitchBook Platform

ADial Pharmaceuticals

Description

Developer of prescription medications designed to treat addictions and related disorders. The company's prescription medications offers advanced compound AD04 specifically targets alcohol use disorder and offers a simple blood test which can identify those patients who respond to treatment with AD04, enabling medical professionals to treat addiction diseases and disorders, including alcohol and drug addictions as well as for behaviors such as those related to obesity and eating disorders.

2007

Founded

IPO REG.

Status

1-10

Employees

IPO

Latest Deal Type

$14M

Latest Deal Amount

$20.8M

Total Amount Raised

Description

Developer of prescription medications designed to treat addictions and related disorders. The company's prescription medications offers advanced compound AD04 specifically targets alcohol use disorder and offers a simple blood test which can identify those patients who respond to treatment with AD04, enabling medical professionals to treat addiction diseases and disorders, including alcohol and drug addictions as well as for behaviors such as those related to obesity and eating disorders.

Website:

www.adialpharma.com

Ownership Status

In IPO Registration

Financing Status

Corporate Backed or Acquired

Primary Industry

Pharmaceuticals

Other Industries

Biotechnology
Drug Delivery

Primary Office

204 East High Street Suite 100 Charlottesville, VA 22902United States +1 (434) 422-9800
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore ADial Pharmaceuticals's full profile, request a free trial.

ADial Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

ADial Pharmaceuticals Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
LindéngruppenCorporationMinority000 0000000 0000
Lindéngruppen Corporation

ADial Pharmaceuticals Executive Team (3)

NameTitleBoard
Seat
Contact
Info
William Stilley IIIPresident, Chief Executive Officer and Board Member
Bankole Johnson Ph.DCo-Founder, Chairman and President
John RiccardiChief Financial Officer
William Stilley III President, Chief Executive Officer and Board Member
Bankole Johnson Ph.D Co-Founder, Chairman and President
John Riccardi Chief Financial Officer

ADial Pharmaceuticals Board Members (9)

NameRepresentingRoleSinceContact
Info
Bankole Johnson Ph.DADial PharmaceuticalsCo-Founder, Chairman and President000 0000
James Newman Jr.ADial PharmaceuticalsBoard Member000 0000
J. Kermit AndersonADial PharmaceuticalsBoard Member000 0000
Joacim BjörkLindéngruppenSenior Vice President and CLO000 0000
Leonard Meyer Jr.ADial PharmaceuticalsBoard Member000 0000
Bankole Johnson Ph.D Co-Founder, Chairman and President ADial Pharmaceuticals
James Newman Jr. Board Member ADial Pharmaceuticals
J. Kermit Anderson Board Member ADial Pharmaceuticals
Joacim Björk Senior Vice President and CLO Lindéngruppen
Leonard Meyer Jr. Board Member ADial Pharmaceuticals
Request full access to PitchBook